UBS AM’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.48M | Buy |
294,383
+95,320
| +48% | +$480K | ﹤0.01% | 2275 |
|
|
2025
Q1 | $1.29M | Buy |
199,063
+17,738
| +10% | +$115K | ﹤0.01% | 2200 |
|
|
2024
Q4 | $1.33M | Buy |
181,325
+40,954
| +29% | +$301K | ﹤0.01% | 2234 |
|
|
2024
Q3 | $1.05M | Sell |
140,371
-30,188
| -18% | -$226K | ﹤0.01% | 2369 |
|
|
2024
Q2 | $1.52M | Buy |
170,559
+78,500
| +85% | +$699K | ﹤0.01% | 2143 |
|
|
2024
Q1 | $933K | Hold |
92,059
| – | – | ﹤0.01% | 2049 |
|
|
2023
Q4 | $926K | Buy |
92,059
+11,645
| +14% | +$117K | ﹤0.01% | 2064 |
|
|
2023
Q3 | $753K | Sell |
80,414
-8,829
| -10% | -$82.7K | ﹤0.01% | 2113 |
|
|
2023
Q2 | $2.08M | Hold |
89,243
| – | – | ﹤0.01% | 1626 |
|
|
2023
Q1 | $2.08M | Buy |
89,243
+17,498
| +24% | +$407K | ﹤0.01% | 1626 |
|
|
2022
Q4 | $1.82M | Buy |
71,745
+8,514
| +13% | +$215K | ﹤0.01% | 1568 |
|
|
2022
Q3 | $1.22M | Sell |
63,231
-15,335
| -20% | -$296K | ﹤0.01% | 1854 |
|
|
2022
Q2 | $2M | Buy |
78,566
+11,086
| +16% | +$282K | ﹤0.01% | 1612 |
|
|
2022
Q1 | $1.74M | Buy |
67,480
+2,438
| +4% | +$62.7K | ﹤0.01% | 1863 |
|
|
2021
Q4 | $2.72M | Buy |
65,042
+1,323
| +2% | +$55.4K | ﹤0.01% | 1724 |
|
|
2021
Q3 | $2.77M | Buy |
63,719
+549
| +0.9% | +$23.9K | ﹤0.01% | 1684 |
|
|
2021
Q2 | $2.99M | Buy |
63,170
+53,111
| +528% | +$2.51M | ﹤0.01% | 1664 |
|
|
2021
Q1 | $516K | Hold |
10,059
| – | – | ﹤0.01% | 2376 |
|
|
2020
Q4 | $269K | Sell |
10,059
-118,199
| -92% | -$3.17M | ﹤0.01% | 2434 |
|
|
2020
Q3 | $4.4M | Sell |
128,258
-21,599
| -14% | -$741K | ﹤0.01% | 1207 |
|
|
2020
Q2 | $6.14M | Buy |
+149,857
| New | +$6.14M | ﹤0.01% | 1045 |
|